Literature DB >> 15830218

The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions.

Nils Krone1, Felix G Riepe, Joachim Grötzinger, Carl-Joachim Partsch, Jürgen Brämswig, Wolfgang G Sippell.   

Abstract

Congenital adrenal hyperplasia (CAH) [OMIM 201910] is a group of autosomal recessive disorders, caused in 90-95% of cases by a deficiency of steroid 21-hydroxylase due to mutations in the CYP21A2 gene. The functional and structural effects of a novel rare missense mutation (E351K) in CYP21A2 found in a male patient with simple virilizing CAH were studied. The novel E351K point mutation is located in the ERR triad of the 21-hydroxylase. The ERR triad is a glutamine-arginine-arginine motif conserved in all cytochrome P450 sequences. The glutamate and first arginine residue are invariant in all P450 cytochrome enzymes, whereas the second arginine residue is present as arginine, histidine, or asparagine. Although the ERR triad is involved in some way to heme binding by the cytochrome P450 monooxygenases, the E351K mutation leads to severe but not complete loss of CYP21 enzyme activity. The functional analysis in COS-7 cells revealed a reduced conversion of 17-hydroxyprogesterone to 11-deoxycortisol of 1.1+/-0.5% (SD) and of progesterone to 11-deoxycorticosterone of 1.2+/-0.3% of wild-type activity. Analyzing the artificial mutants (E351D, E351I) of the E351 residue did not show a restoration of the in vitro 21-hydroxylase activity. These effects could be readily explained by structural changes induced by the mutations, which were rationalized by a three-dimensional-model structure of the CYP21 protein. The combination of in vitro enzyme function and computerized protein analysis of the E351 residue of the CYP21 protein provides experimental evidence for the ERR triad being a fundamental structural element of cytochrome P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830218     DOI: 10.1007/s00109-005-0655-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

2.  Site-directed mutageneses of rat liver cytochrome P-450d: catalytic activities toward benzphetamine and 7-ethoxycoumarin.

Authors:  H Furuya; T Shimizu; K Hirano; M Hatano; Y Fujii-Kuriyama; R Raag; T L Poulos
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

3.  A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction.

Authors:  S Lajic; A Levo; A Nikoshkov; Y Lundberg; J Partanen; A Wedell
Journal:  Hum Genet       Date:  1997-06       Impact factor: 4.132

4.  CYP21 mutations in simple virilizing congenital adrenal hyperplasia.

Authors:  S Lajić; T Robins; N Krone; H P Schwarz; A Wedell
Journal:  J Mol Med (Berl)       Date:  2001-10       Impact factor: 4.599

5.  Hydrogen bond network of cytochrome P-450cam: a network connecting the heme group with helix K.

Authors:  K Yoshikawa; T Noguti; M Tsujimura; H Koga; T Yasukochi; T Horiuchi; M Go
Journal:  Biochim Biophys Acta       Date:  1992-07-13

6.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation.

Authors:  S M Baumgartner-Parzer; E Schulze; W Waldhäusl; S Pauschenwein; S Rondot; P Nowotny; K Meyer; H Frisch; F Waldhauser; H Vierhapper
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

8.  CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.

Authors:  Nike M M L Stikkelbroeck; Lies H Hoefsloot; Ilse J de Wijs; Barto J Otten; Ad R M M Hermus; Erik A Sistermans
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

9.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.

Authors:  M C Carroll; R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.

Authors:  Y Higashi; H Yoshioka; M Yamane; O Gotoh; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  1 in total

1.  Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.

Authors:  Constanze Wiek; Eva M Schmidt; Katharina Roellecke; Marcel Freund; Mariko Nakano; Edward J Kelly; Wolfgang Kaisers; Vladimir Yarov-Yarovoy; Christof M Kramm; Allan E Rettie; Helmut Hanenberg
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.